← Leaderboards
Sunghee Kim
Biopowertech
$1,623,966
Attributed
$1,623,966
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $335.3K · FY2006–15$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,623,966 · 8
By mechanism
R43$1,623,966 · 8
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsCellsFutureDecoy Receptor 3CytokineMedicalInsightRecombinantsTumor Necrosis Factor ReceptorFamilyReceptorApoptosisSerumEnzyme-Linked Immunosorbent AssayModalityLigandsIn VivoMediatingPathogenesisFeasibility StudiesCancer PatientEvaluationImmune ResponseBinding (Molecular Function)
Grant awards (8)
A novel biomarker of infection in neutropenic cancer patients$311,003
R43 · FY2015 · AI · contact PI
Development of recombinant rhTL1A protein for cancer treatment$329,560
R43 · FY2010 · CA · contact PI
Targeting Deceoy Receptor 3 in Breast Cancer$335,322
R43 · FY2008 · CA · contact PI
A novel therapy for sepsis$203,439
R43 · FY2007 · AI · contact PI
Development of immunoassay to measure a novel TNF-like protein$115,389
R43 · FY2007 · GM · contact PI
A therapeutic potential of soluble decoy receptor 3 in sepsis$112,572
R43 · FY2006 · GM · contact PI
Decoy receptor 3 and liver cirrhosis$109,681
R43 · FY2006 · DK · contact PI
Soluble Decoy Receptor 3 in Bacterial Infection and Sepsis$107,000
R43 · FY2006 · GM · contact PI